![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Biomagnetics Diagnostics Corp (CE) | USOTC:BMGP | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP - News) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced its plans to spin off its Chinese bio-fuels operation, Zhuhai Oil Energy Sciences and Technology, located in Guangdong Province, China, into a separate publicly traded entity.
Over the past few months, the management team at Biomagnetics has been working on a structure that it believes will maximize shareholder value. The Company has been interviewing investment groups to facilitate this transaction. The new Company, which will trade on the OTCBB as a fully reporting organization with the SEC, will enter into a contract with Biomagnetics to purchase all intellectual property and contract rights to the proprietary low carbon fuel formulations.
“A green revolution is sweeping through China resulting in a critical demand for low carbon bio-fuels. These unique formulations greatly reduce particulate and carbon emissions while still being cost competitive,” commented Clayton Hardman, CEO of Biomagnetics. “We are negotiating specific terms while waiting for GAAP certified audits. Specific terms to finalize include capital compensation and percentage interest in the new company Biomagnetics will receive for selling its Bio-Fuel rights. This should add to shareholder value, and reduce or eliminate future shareholder dilution.”
About Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company is currently developing a waveguide-based advanced integrated optical biosensor through its cooperative research and development agreement with Los Alamos National Security, LLC, which will initially be used for cholera, tuberculosis and malaria diagnosis. More information on Biomagnetics Diagnostics Corp. can be seen at www.biomagneticsbmgp.com.
1 Year Biomagnetics Diagnostics (CE) Chart |
1 Month Biomagnetics Diagnostics (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions